- NORTH AMERICA EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Alkane Resources Expects Approval for $1 Billion Rare Earths Project in Q1 2015
Alkane Resources (ASX:ALK) expects to receive approval for its billion dollar rare earths project in Australia in the first quarter of 2015, according to the Sydney Morning Herald. The company anticipates that the approval could facilitate a share rerating for the company.
Alkane Resources (ASX:ALK) expects to receive approval for its billion dollar rare earths project in Australia in the first quarter of 2015, according to the Sydney Morning Herald. The company anticipates that the approval could facilitate a share rerating for the company.
As quoted in the publication:
Ahead of the receipt of government approvals for Alkane’s rare earths project, which is located near Dubbo in western NSW, Alkane has launched detailed engineering studies so that once the green light is received, it can finalise the financing and fast-track work on the project.
Unlike Lynas and Molycorp, Alkane will not be processing its rare earths itself, but selling the material to third parties for treatment, which significantly reduces its risk profile.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.Â